Consortium off to the BSGCT 2016

Thursday, April 14th 2016

Print this page

BSGCT_logo.jpgTomorrow (Friday 15 April) marks the British Society for Gene and Cell Therapy Annual Conference at the ICH in London. On alternate years the BSGCT conference is a one day event and this year the focus is on adeno associated virus vectorology. The programme has the title 'AAV in 2016: Biology, vector design and implementation into human gene therapy' and it promises to be a very interesting day.

The Consortium isn't heavily represented (as this really isn't a technology we specialise in) but one of our students, Agata Antepowicz, is presenting a poster on her work. Our students are funded outside of our core CF Gene Therapy funding so they get to work on different technologies which although removed from CF, allow us to learn a lot and build up our knowledge in different areas.

Agata is using the gene therapy platforms we have developed to assess whether they can be used to deliver monoclonal antibodies and you can download her poster from the link below:-

Development of lung and muscle protein factories to deliver therapeutic monoclonal antibodies

Our students will be providing updates from the Conference via Twitter @genemed

Other content


Large scale lentivirus production in suspension culture.


Mouse lung large airway (cell nuclei blue) transduced with an adenoviral vector (green).


A frozen vial of GL67A (left) and a frozen vial of pGM169 plasmid DNA (right)